Data and models determine treatment proposals--an illustration from meta-analysis

Area of Science:

• Biostatistics
• Clinical Epidemiology
• Medical Research Methodology

Background:

• Meta-analysis is crucial for synthesizing evidence but faces challenges with heterogeneity among trial results.
• Standard meta-analysis models include the equal effects model (assuming homogeneity) and the fixed effects model (conserving individual results).
• Heterogeneity can lead to conflicting interpretations and decisions in clinical practice.

Purpose of the Study:

• To explore the implications of different meta-analysis models on interpreting trial results, particularly in the presence of heterogeneity.
• To introduce the random effects model as a more flexible approach that 'shrinks' individual effect sizes towards an overall mean.
• To highlight how model choice can influence the perceived benefit or harm of an intervention.

Main Methods:

• Comparison of three meta-analysis approaches: equal effects model, fixed effects model, and random effects model.
• Discussion of the 'shrinking' effect in the random effects model, where individual trial results are adjusted based on overall findings.
• Emphasis on graphical comparisons to aid decision-making when individual trial outcomes diverge from the mean.

Main Results:

• The choice of meta-analysis model can significantly alter the interpretation of individual trial results, potentially leading to paradoxical conclusions.
• The random effects model offers a more nuanced approach, especially when an individual trial's outcome differs substantially from the average.
• Different models may classify the same trial result as beneficial or harmful, underscoring the importance of model selection.

Conclusions:

• Understanding the differences between equal effects, fixed effects, and random effects models is critical for accurate meta-analysis interpretation.
• The random effects model provides a flexible tool that can help reconcile discordant trial results and guide clinical decisions.
• Transparent reporting and graphical representation of different model applications are essential for evidence-based medicine.